National Institute of Child Health and Human Development; Notice of Meeting, 1225-1226 [07-6292]

Download as PDF 1225 Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices ESTIMATED ANNUALIZED BURDEN TABLE—Continued Number of respondents Agency Total ........................................................................................................ Dated: December 20, 2007. Terry Nicolosi, Office of the Secretary, Director, Office of Resources Management. [FR Doc. E7–25431 Filed 1–4–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007N–0487] Meeting Being Planned to Obtain Public Input for Ensuring the Safety of Pet Food Food and Drug Administration, HHS Notice of intent to schedule and hold public meeting. pwalker on PROD1PC71 with NOTICES ACTION: SUMMARY: The Food and Drug Administration (FDA) is announcing its intention to schedule and hold a public meeting early in 2008 to obtain input from stakeholder groups, including, but not limited to, the Association of American Feed Control Officials (AAFCO), veterinary medical associations, animal health organizations, and pet food manufacturers for the development of ingredient, processing, and labeling standards to ensure the safety of pet food. These standards were mandated by the FDA Amendments Act of 2007 (FDAAA). Date, Time, and Location: The date, time, and location for the 2008 public meeting will be announced in a subsequent notice that will be published in the Federal Register a later date. Addresses: A docket has been opened at FDA to receive any comments in advance of the public meeting. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to either https://www.fda.gov/dockets/ecomments or https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Walter Osborne, Center for Veterinary Medicine (HFV–6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276–9024, VerDate Aug<31>2005 19:05 Jan 04, 2008 Jkt 214001 Average burden per response (in hours) ........................ .......................... ........................ FAX: 240–276–9101, or e-mail: walter.osborne@fda.hhs.gov. SUPPLEMENTARY INFORMATION: BILLING CODE 4151–AE–P AGENCY: Number of responses per respondent I. Background FDAAA was signed into law by the President on September 27, 2007 (Public Law 110–085). Title X of the FDAAA includes several provisions pertaining to food safety, including the safety of pet food. Sec. 1002(a)of the new law directs that, within 2 years, FDA is to issue new regulations to establish ingredient standards and definitions, processing standards, and updated standards for labeling to include nutritional and ingredient information. This same provision of the law also directs that, in developing these new regulations, FDA obtain input from its stakeholders, including AAFCO, veterinary medical associations, animal health organizations, and pet food manufacturers. In order to obtain such input, FDA intends to hold a public meeting to hear directly from interested stakeholders. II. Public Meeting Details Because FDA is mandated by Congress to establish the new pet food requirements within 2 years of enactment of the FDAAA, it is imperative that the agency begin the rulemaking process as soon as possible. To that end, FDA intends to hold a public meeting in the greater Rockville, MD area sometime within the first 3 months of 2008. After the meeting, FDA will review all of the comments submitted to the docket prior to initiating the regulation drafting process. III. Comments FDA will publish a subsequent notice in the Federal Register announcing the details of the 2008 public meeting. However, anyone wishing to submit general comments about the new law as it relates to pet food safety or the planned public meeting may do so to the Division of Dockets Management (see Addresses). Submit a single copy of electronic comments or two paper copies of any written comments, except that individuals may submit one paper copy. Comments should be identified with the full title and the docket PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Total burden hours 807 number found in brackets in the heading of this document. Received comments will be available for public examination in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. You may also view received comments on the FDA’s Internet site at: https://www.fda.gov/ ohrms/dockets. Dated: December 27, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–25599 Filed 1–4–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Child Health and Human Development Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Child Health and Human Development Council. Date: January 24, 2008. Open: 8 a.m. to 12:15 p.m. E:\FR\FM\07JAN1.SGM 07JAN1 1226 Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices Agenda: (1) A report by the Director, NICHD; (2) Obstetric and Pediatric Pharmacology Branch Presentation; (3) a report of the subcommittee on Planning and Policy; and other business of the Council. Place: National Institutes of Health, Building 31, 31 Center Drive, C-Wing, Conference Room 6, Bethesda, MD 20892. Closed: 1:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 31 Center Drive, C-Wing, Conference Room 6, Bethesda, MD 20892. Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National Institute of Child Health and Human Development, NIH, 9000 Rockville Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892, (301) 496–1848. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.nichd.nih.gov/about/nachhd.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program. National Institutes of Health, HHS) Dated: December 27, 2007. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–6292 Filed 01–04–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health pwalker on PROD1PC71 with NOTICES National Institute of Mental Health; Notice of Workshops Notice is hereby given of a series of four scientific workshops organized by the Interagency Autism Coordinating Committee (IACC). The workshops will be closed to the public with attendance limited to invited participants. The purpose of the scientific workshops is to generate research priorities that will be used to VerDate Aug<31>2005 19:05 Jan 04, 2008 Jkt 214001 develop the IACC strategic plan for Autism Spectrum Disorder (ASD) research. The next meeting of the IACC when research priorities will be discussed is March 14, 2008. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: Scientific workshops. Date: January 15–18, 2008. Time: 9 a.m. to 5 p.m. each day. Agenda: Review of research accomplishments, funding initiatives and research resources for ASD by scientists and other ASD stakeholders; discussion and generation of high priority research areas and initiatives for developing the IACC strategic plan for ASD research. Place: The Westin Arlington Gateway, 801 North Glebe Road, Arlington, VA 22203, 703–717–6200. Contact Person: Joyce Y. Chung, MD, Interagency Autism Coordinating Committee, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 6198, Bethesda, MD 20892–9669, 301–443–3621. Information about the IACC is available on the Web site: https://www.nimh.nih.gov/ research-funding/scientific-meetings/ recurring-meetings/iacc/index.shtml. Dated: December 27, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–6293 Filed 1–4–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse Draft Strategic Plan National Institute on Drug Abuse, NIH, HHS. ACTION: Notice. AGENCY: SUMMARY: The National Institute on Drug Abuse (NIDA) is developing a strategic plan for the next 5 years, and invites the public to provide comments on a draft of this plan. The draft plan will be publicly available through the NIDA Draft Strategic Plan Web page (https://www.drugabuse.gov/ StrategicPlan/) for 30 days from the publication of this Notice. The public is invited to provide comments via the e-mail address or the postal address listed on the NIDA Draft Strategic Plan Web page. Background: NIDA is the lead Federal agency for research on drug abuse and addiction. For the past three decades, NIDA has led the way in supporting research to prevent and treat drug abuse and addiction and mitigate the impact of their consequences—particularly the spread of HIV/AIDS and other infectious PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 diseases. Given recent revolutionary advances in drug abuse research, NIDA has recently undergone a strategic planning process gathering recommendations from the National Advisory Council on Drug Abuse and from ongoing dialogue with our various stakeholder groups to establish achievable goals and objectives for the future. NIDA’s draft Strategic Plan outlines four major goal areas—Prevention, Treatment, HIV/AIDS, and Cross Cutting Priorities—each with Strategic Objectives that will guide NIDA’s research agenda for the future. The public is invited to review this draft plan and provide comments. The draft plan may be viewed at https:// www.drugabuse.gov/StrategicPlan/ Index.html, and hard copies are available by calling 301–443–1124 or by sending a letter requesting a copy (that includes your mailing address) to: National Institute on Drug Abuse, Attn: Draft Strategic Plan, 6001 Executive Blvd., Suite 5213, MSC 9561, Bethesda, MD 20892–9561. Request for Comments: The public is invited to provide comments on the draft Strategic Plan. Comments may be sent to the email address listed on the NIDA Strategic Planning Web page at https://www.drugabuse.gov/ StrategicPlan/, or to the postal address listed above. Comments Due Date: Comments regarding NIDA’s draft Strategic Plan should be submitted via e-mail to stratplan@nida.nih.gov no later than 30 days after the publication of this Notice. Comments mailed to the above postal address must be postmarked by the same date. Dated: December 21, 2007. Nora D. Volkow, Director, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. E7–25521 Filed 1–4–08; 11:28 am] BILLING CODE 4140–01–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5121–N–35] Notice of Proposed Information Collection: Comment Request Loan Sales Bidder Qualification Statement Office of the Assistant Secretary for Housing—Federal Housing Commissioner, HUD. ACTION: Notice. AGENCY: SUMMARY: The proposed information collection requirement described below will be submitted to the Office of E:\FR\FM\07JAN1.SGM 07JAN1

Agencies

[Federal Register Volume 73, Number 4 (Monday, January 7, 2008)]
[Notices]
[Pages 1225-1226]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6292]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Advisory Child Health and Human Development Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Child Health and Human 
Development Council.
    Date: January 24, 2008.
    Open: 8 a.m. to 12:15 p.m.

[[Page 1226]]

    Agenda: (1) A report by the Director, NICHD; (2) Obstetric and 
Pediatric Pharmacology Branch Presentation; (3) a report of the 
subcommittee on Planning and Policy; and other business of the 
Council.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
    Closed: 1:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National 
Institute of Child Health and Human Development, NIH, 9000 Rockville 
Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892, (301) 
496-1848.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.nichd.nih.gov/about/nachhd.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program. National 
Institutes of Health, HHS)

    Dated: December 27, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-6292 Filed 01-04-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.